Success Metrics

Completion Rate
0%(0/3)
Active Trials
2(29%)
Terminated
3(43%)

Phase Distribution

Ph phase_3
2
29%
Ph phase_2
4
57%
Ph not_applicable
1
14%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Terminated(3)
Other(2)

Detailed Status

Terminated3
unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (57.1%)
Phase 32 (28.6%)
N/A1 (14.3%)

Trials by Status

unknown229%
terminated343%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7